PATENT CLAIM ANALYSIS

Application Number: 15863328
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "190100"]

Abstract:
The invention relates to compositions, methods and therapies for the treatment of inflammation caused by infection with  Propionibacterium acnes . The compositions include a combination of peptide and anti-TNF. The peptide consists of a specific amino acid sequence or a peptide consisting of an amino acid sequence derived the specific amino acid sequence by deletion, substitution, insertion or addition of one or more amino acids. The administration of the peptide and anti-TNF in therapeutically effective amounts to a patient is effective to suppress, by immune response, inflammation caused by infection with  Propionibacterium acnes.

Claim (Index 3):
A method of suppressing inflammation caused by infection with  Propionibacterium acnes  in a patient, comprising:\n introducing into the patient a peptide consisting of an amino acid sequence of SEQ NO. 3; and introducing into the patient a TNF inhibitor.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 86.0
- Lexical Diversity: 1.94231
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14312162', '13380425', '13132905', '15559984', '13925067']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6881597962946805
- 35 USC 102 Novelty (BERT): 0.5760714240708181
- Combined Prediction Score: 0.6769509590722942
- Mean Citation Score: 302.836734
- Max Citation Score: 453.46738
- Similarity Product: 415.2268441190517

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test